ARCH BIOPARTNERS INC (ARCH.CA) Stock Income Statement
TSX-V:ARCH • CA03938C1041
0.77 CAD
-0.03 (-3.75%)
Last: Mar 9, 2026, 07:00 PM
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 158.10K | 275.90K | 2.12M | 1.98M | 964.70K | |||
| Operating Expenses | 2.59M | 1.52M | 5.68M | 4.98M | 2.04M | |||
| Research and Development | N/A | -9.50K | 3.65M | 1.94M | 1.27M | |||
| Selling, General, and Administrative Expenses | 2.23M | 1.53M | 2.03M | 3.04M | 772.60K | |||
| Operating Income | -2.43M | -1.24M | -3.56M | -3.00M | -1.08M | |||
| Interest Income/Expense | -261.20K | -311.10K | -369.40K | -330.50K | -327.80K | |||
| Other Income/Expense | N/A | 0.00 | 6.80K | N/A | N/A | |||
| Income Before Taxes | -2.70M | -1.55M | -3.92M | -3.33M | -1.41M | |||
| Net Income | -2.70M | -1.55M | -3.92M | -3.33M | -1.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.06 | -0.05 | -0.02 | |||
| Non GAAP EPS | N/A | N/A | N/A | -0.05 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -1705.19% | -562.78% | -184.76% | -167.71% | -145.94% | |||
| Operating Profit Margin | -1539.91% | -450.05% | -167.67% | -151.05% | -111.95% | |||
All data in CAD